2-chloro-n(6)cyclopentyladenosine and Parkinson Disease

2-chloro-n(6)cyclopentyladenosine has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cristalli, G; Morelli, M; Pinna, A; Volpini, R	1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and Parkinson Disease

Article	Year
New adenosine A2A receptor antagonists: actions on Parkinson's disease models. European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3 Topics: Adenine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Synergism; Levodopa; Male; Molecular Structure; Parkinson Disease; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tritium	2005

Article

Year

New adenosine A2A receptor antagonists: actions on Parkinson's disease models.

European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

Topics: Adenine; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Drug Synergism; Levodopa; Male; Molecular Structure; Parkinson Disease; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tritium

2005